Skip to content

Bright Light: A Novel Treatment for Anxiety

Bright Light: A Novel Treatment for Anxiety

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01064700
Enrollment
33
Registered
2010-02-08
Start date
2006-10-31
Completion date
2007-12-31
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Sleep

Keywords

Anxiety, Phototherapy, Psychic Anxiety

Brief summary

The primary aim of this research was to examine the influence of bright light on anxiety in high-anxious young adults. In an acute exposure study, participants were randomly assigned to 45 min of either (1) bright light (3,000 lux) or (2) a placebo inactivated negative ion generator. Treatments were initiated ≤1 hr after awakening. At 10 min before and 30 min after the treatments, state anxiety, mood, and blood pressure were assessed. Following the acute exposure study, participants performed a 5-week study. Following a a 1-week baseline, participants were randomly assigned to four weeks of daily exposure to either (1) bright light (45 min/day; 3,000 lux) or (2) placebo inactivated negative ion generator, which were initiated ≤1 hr after awakening. Before and after the experiment, clinical ratings were conducted with the Hamilton Anxiety Scale, the Hamilton Depression Scale, and the Clinical Global Impressions scale (CGI). Following baseline, and following each week of treatment, blood pressure, as well as questionnaires for state anxiety, depression, mood, sleep, and side effects were assessed.

Interventions

DEVICELitebook Bright Light Box

Four weeks of daily exposure to bright light (3,000 lux) for 45 min/day, beginning within 60 min of arising.

DEVICELitebook inactivated negation ion generator (the placebo)

Four weeks of daily exposure to inactivated negative ion generator for 45 min/day, beginning within 60 min of arising

Sponsors

Liteboook Company
CollaboratorUNKNOWN
University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Having a level of trait anxiety \[Spielberger State-Trait Anxiety Inventory (Form Y1)\]{23642} that was ≥ the 75th percentile for their age (i.e., ≥ 46 and ≥ 44 for women and men, respectively)

Exclusion criteria

* Current treatment for anxiety or depression; * History of bipolar disorder, mania, or psychotic disorders; * History of winter depression, which might bias towards positive response to light; * Hypertension; * Ophthalmic abnormalities; and * Usual exposure to high levels of light such that the intervention would add little to usual exposure.

Design outcomes

Primary

MeasureTime frameDescription
Spielberger State Anxiety Inventory5 weeksstate anxiety questionnaire
Hamilton Anxiety5 weeksHamilton Anxiety Questionnaire

Secondary

MeasureTime frameDescription
Beck Depression Inventory5 weeksself-report depression questionnaire
Pittsburgh Sleep Quality Inventory5 weeksPSQI, a common sleep quality questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026